Cardiovascular disease has become one of the most health threatening diseases and is now the leading cause of death in the Chinese population, with mortality rate higher than cancer and other diseases. Major cardiovascular diseases among the Chinese population are strokes and coronary heart diseases, both of which increased significantly. For this reason, studies on cardiovascular drugs received extensive attention. Clinical drugs are diversified and are mainly used for the cardiac and vascular system to improve heart function and blood circulation.
CYP2C9和VKORC1 gene polymorphism
CYP2C19 gene polymorphism
Ischemic cerebral thrombosis
ALDH2 gene polymorphism